Skip to main content
Log in

Short- or longer-term treatment: similar costs in Lyme disease

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2015 euros

Reference

  • Berende A, et al. Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease. PLOS One : 2 Apr 2018. Available from: URL: https://doi.org/10.1371/journal.pone.0195260

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Short- or longer-term treatment: similar costs in Lyme disease. PharmacoEcon Outcomes News 801, 32 (2018). https://doi.org/10.1007/s40274-018-4887-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4887-1

Navigation